Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
BioData Catalyst is a cloud-based ecosystem with data and analytic capabilities to advance research on heart, lung, blood, and sleep diseases, disorders, and conditions.
CEAL is helping communities hardest hit by COVID-19. Learn more about CEAL and its programs.
Cholesterol is a waxy, fat-like substance the body needs for good health but in the right amounts. Unhealthy levels of cholesterol can lead to heart and blood vessel diseases.
Learn about different treatments for lung diseases and conditions.
Insomnia is a common sleep disorder that causes you to have trouble falling asleep, staying asleep, or getting good quality sleep.
A heart attack, also known as myocardial infarction, happens when the flow of blood that brings oxygen to your heart suddenly becomes blocked and your heart can’t get enough oxygen.
Anemia is a condition in which the blood has a lower-than-normal amount of healthy red blood cells.
LAM, or lymphangioleiomyomatosis, is a rare lung disease in which abnormal cells begin to grow out of control in the lungs. Over time, these cells can destroy healthy lung tissue.
The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.